The new cancer test is important, because its developer say it can detect ovarian cancer at its early stages.
“Innovation is that our tool can detect of ovarian cancer, irrespective of type of tumour. No matter what type of tumour is, we can detect it anyway, second we detect this kinds no matter of how advanced it is, so we detect what is the most important in detecting ovarian cancer in the early forms of this disease.”
An estimated one in 75 women will developed ovarian cancer over their life time, and the early detection can greatly improve the chances for survival.
“Our test is not based on only one molecule, but its based on 7 micro RNA molecules.Thanks to these latest data annalist effort, we are able to construct the test that is more effective then we have be able to create until now.”
So far the test is proved effective catching a large majority of ovarian cancers, but there is still some problems to work out.
“We were able to detect and find nine out of ten cases of disease in the population,the problem is that we can detect unfortunately a certain pull of so called false positives,people who were appear to be ill and,in fact, do not have the disease, and that was we are working on,ensuring the people who have a positive result are really sick.”
As with almost all new technologies, the team is working on ways to make the test is more effective and cheaper and then getting it on the market.
Kevin Enochs VOA News.